Plain-English translation of NCT06729541 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a personalized approach to treating three serious mental health conditions: depression, bipolar disorder, and schizophrenia. Instead of using a one-size-fits-all approach, doctors will use genetic testing and careful symptom tracking to choose the best medication and dose specifically for you. The goal is to help you get better results with fewer side effects.
Many people with these mental health conditions don't respond well to their first medication, or they experience troublesome side effects. This study aims to solve that problem by using genetic information and detailed symptom assessments to match the right medication to the right person from the start, potentially helping more people recover faster and more safely.
You likely qualify if…
You likely don't qualify if…
You will receive genetic testing that identifies which medications are likely to work best for you based on your DNA. Within a week, your doctor will use these results—along with a detailed assessment of your symptoms—to select or adjust your medication and dose. You'll be monitored closely for 10 weeks with regular check-ins to see how well the treatment is working and to ensure it's safe. Blood tests may be used to track medication levels and ensure you're on the right dose.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China